Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Prestwick Seeks $75M IPO, Readies Tetrabenazine NDA

April 26, 2005

By Jennifer Boggs

Hamilton Pharmaceuticals' First Financing: $11M For CNS Drugs

April 25, 2005

By Jennifer Boggs

Hamilton Pharmaceuticals' First Financing: $11M For CNS Drugs

April 25, 2005

By Jennifer Boggs

Genzyme Beats Consensus, Increases Full-Year Guidance

April 22, 2005

By Jennifer Boggs

Genzyme Beats Consensus, Increases Full-Year Guidance

April 22, 2005

By Jennifer Boggs

Corgentech Cuts Staff To Slow Spending After E2F Decoy Miss

April 21, 2005

By Jennifer Boggs

Molecular Insight Raises $28M In Series C For Imaging Product

April 21, 2005

By Jennifer Boggs

Molecular Insight Raises $28M In Series C For Imaging Product

April 21, 2005

By Jennifer Boggs

Corgentech Cuts Staff To Slow Spending After E2F Decoy Miss

April 21, 2005

By Jennifer Boggs

Agennix Reports Positive NSCLC Data With Talactoferrin, Chemo

April 20, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...